Cargando…
Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells
PURPOSE: Wasabi is a traditional plant seasoning with an anti-septic function. Recent studies revealed several functions of Wasabi, such as anti-inflammation; however, the anti-tumor effect against endometrial carcinoma (EMC) cells has not been examined. In the present study, we investigated the ant...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871149/ https://www.ncbi.nlm.nih.gov/pubmed/36689027 http://dx.doi.org/10.1007/s12672-023-00617-2 |
_version_ | 1784877105231691776 |
---|---|
author | Ono, Motoki Miyamoto, Tsutomu Fuseya, Chiho Asaka, Ryoichi Ando, Hirofumi Tanaka, Yasuhiro Shinagawa, Manaka Yokokawa, Yusuke Takeuchi, Hodaka Horiuchi, Akiko Shiozawa, Tanri |
author_facet | Ono, Motoki Miyamoto, Tsutomu Fuseya, Chiho Asaka, Ryoichi Ando, Hirofumi Tanaka, Yasuhiro Shinagawa, Manaka Yokokawa, Yusuke Takeuchi, Hodaka Horiuchi, Akiko Shiozawa, Tanri |
author_sort | Ono, Motoki |
collection | PubMed |
description | PURPOSE: Wasabi is a traditional plant seasoning with an anti-septic function. Recent studies revealed several functions of Wasabi, such as anti-inflammation; however, the anti-tumor effect against endometrial carcinoma (EMC) cells has not been examined. In the present study, we investigated the anti-tumor effect of 6-(methylsulfinyl) hexyl isothiocyanate (6-MITC), a major chemical compound of Wasabi, against various EMC cell lines in vitro and in vivo. METHODS: The effect of 6-MITC on cell viability was measured by the WST-1 assay in EMC and HUVEC cells. The impact of 6-MITC oral administration in nude mice was measured to assess the growth of the EMC xenograft and natural killer (NK) cell activity in the spleen. RESULTS: The addition of 6-MITC suppressed the proliferation of EMC cells (Ishikawa, HEC265, HEC108, KLE, and HEC1B) dose-dependently, but not HUVEC cells. 6-MITC (5 µM) enhanced the cisplatin sensitivity of EMC cells. 6-MITC induced apoptosis in a dose-dependent fashion in EMC cells other than HEC1B cells and was associated with increased expression of cleaved-caspase3 and decreased expression of BCL2. Oral administration of 6-MITC (2 and 4 µmol/kg) to Ishikawa and HEC1B xenografting mice resulted in a reduced tumor volume compared with the control (P < 0.05, 4 µmol/kg). Immunohistochemical staining of resected tumors revealed increased expression of Ki-67 and reduced cleaved-caspase3. Furthermore, 6-MITC treatment enhanced NK cell activity, especially when administered before tumor xenografting. CONCLUSION: These results indicate that 6-MITC has a marked anti-tumor effect against EMC cells and a novel effect to enhance NK cell activity. These effects suggest the therapeutic potential of 6-MITC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-023-00617-2. |
format | Online Article Text |
id | pubmed-9871149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-98711492023-01-25 Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells Ono, Motoki Miyamoto, Tsutomu Fuseya, Chiho Asaka, Ryoichi Ando, Hirofumi Tanaka, Yasuhiro Shinagawa, Manaka Yokokawa, Yusuke Takeuchi, Hodaka Horiuchi, Akiko Shiozawa, Tanri Discov Oncol Research PURPOSE: Wasabi is a traditional plant seasoning with an anti-septic function. Recent studies revealed several functions of Wasabi, such as anti-inflammation; however, the anti-tumor effect against endometrial carcinoma (EMC) cells has not been examined. In the present study, we investigated the anti-tumor effect of 6-(methylsulfinyl) hexyl isothiocyanate (6-MITC), a major chemical compound of Wasabi, against various EMC cell lines in vitro and in vivo. METHODS: The effect of 6-MITC on cell viability was measured by the WST-1 assay in EMC and HUVEC cells. The impact of 6-MITC oral administration in nude mice was measured to assess the growth of the EMC xenograft and natural killer (NK) cell activity in the spleen. RESULTS: The addition of 6-MITC suppressed the proliferation of EMC cells (Ishikawa, HEC265, HEC108, KLE, and HEC1B) dose-dependently, but not HUVEC cells. 6-MITC (5 µM) enhanced the cisplatin sensitivity of EMC cells. 6-MITC induced apoptosis in a dose-dependent fashion in EMC cells other than HEC1B cells and was associated with increased expression of cleaved-caspase3 and decreased expression of BCL2. Oral administration of 6-MITC (2 and 4 µmol/kg) to Ishikawa and HEC1B xenografting mice resulted in a reduced tumor volume compared with the control (P < 0.05, 4 µmol/kg). Immunohistochemical staining of resected tumors revealed increased expression of Ki-67 and reduced cleaved-caspase3. Furthermore, 6-MITC treatment enhanced NK cell activity, especially when administered before tumor xenografting. CONCLUSION: These results indicate that 6-MITC has a marked anti-tumor effect against EMC cells and a novel effect to enhance NK cell activity. These effects suggest the therapeutic potential of 6-MITC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-023-00617-2. Springer US 2023-01-23 /pmc/articles/PMC9871149/ /pubmed/36689027 http://dx.doi.org/10.1007/s12672-023-00617-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Research Ono, Motoki Miyamoto, Tsutomu Fuseya, Chiho Asaka, Ryoichi Ando, Hirofumi Tanaka, Yasuhiro Shinagawa, Manaka Yokokawa, Yusuke Takeuchi, Hodaka Horiuchi, Akiko Shiozawa, Tanri Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells |
title | Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells |
title_full | Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells |
title_fullStr | Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells |
title_full_unstemmed | Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells |
title_short | Anti-tumor effect of Wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells |
title_sort | anti-tumor effect of wasabi component, 6-(methylsulfinyl) hexyl isothiocyanate, against endometrial carcinoma cells |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871149/ https://www.ncbi.nlm.nih.gov/pubmed/36689027 http://dx.doi.org/10.1007/s12672-023-00617-2 |
work_keys_str_mv | AT onomotoki antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT miyamototsutomu antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT fuseyachiho antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT asakaryoichi antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT andohirofumi antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT tanakayasuhiro antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT shinagawamanaka antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT yokokawayusuke antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT takeuchihodaka antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT horiuchiakiko antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells AT shiozawatanri antitumoreffectofwasabicomponent6methylsulfinylhexylisothiocyanateagainstendometrialcarcinomacells |